Literature DB >> 6286516

Correction of leg inequality in the Klippel-Trenaunay-Weber syndrome.

M Peixinho, T Arakaki, C S Toledo.   

Abstract

Eight patients with Klippel-Trenaunay-Weber syndrome were treated for leg length inequality of as much as 10 cm in one ten year old, and one thirteen year old. In most cases adequate correction was achieved with epiphyseal stapling during active growth or definitive epiphysiodesis in older children. Bone shortening procedures in full-grown individuals may be indicated but the basic condition may make healing difficult. Ligation of the femoral artery had no effect on the growth of the affected leg.

Entities:  

Mesh:

Year:  1982        PMID: 6286516     DOI: 10.1007/bf00267814

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  5 in total

1.  [Klippel-Trenaunay syndromet medicosurgical considerations].

Authors:  J C GUERRA; F L RANIERI
Journal:  Rev Paul Med       Date:  1961-03

2.  [Not Available].

Authors: 
Journal:  Presse Med       Date:  1945-06-30       Impact factor: 1.228

3.  Control of bone growth by epiphyseal stapling; a preliminary report.

Authors:  W P BLOUNT; G R CLARKE
Journal:  J Bone Joint Surg Am       Date:  1949-07       Impact factor: 5.284

4.  The Klippel-Trenaunay-Weber syndrome: naevus vasculosus osteohy-pertrphicus.

Authors:  J F MULLINS; D NAYLOR; J REDETSKI
Journal:  Arch Dermatol       Date:  1962-08

5.  Orthopaedic treatment of hemangiomatous hypertrophy of the lower extremity.

Authors:  R M Letts
Journal:  J Bone Joint Surg Am       Date:  1977-09       Impact factor: 5.284

  5 in total
  2 in total

1.  [One-stage revision of knee endoprosthesis due to periprosthetic infection and Klippel-Trenaunay syndrome].

Authors:  H-C Schmitz; B Schwantes; D Kendoff
Journal:  Orthopade       Date:  2011-07       Impact factor: 1.087

Review 2.  [Congenital vascular malformations (Hauert disease)].

Authors:  J Hauert; D A Loose; T Dreyer; B Obermayer; A Deibele
Journal:  Orthopade       Date:  2012-06       Impact factor: 1.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.